Startup-162

Startup-162

Bonn, Germany
aimed analytics empowers researchers in pharma and academia to independently analyze complex omics data using a language-based, AI-driven platform that simplifies insights and accelerates discovery.

Startup-160

Startup-160

Greven, Germany
We enable cellular therapies to actually reach their full therapeutic potential. Our technology, C/MB, likely works with many therapeutic platforms and indications.